These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24096150)

  • 1. Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films.
    Hayden RS; Vollrath M; Kaplan DL
    Acta Biomater; 2014 Jan; 10(1):486-93. PubMed ID: 24096150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative characterization of mineralized silk film remodeling during long-term osteoblast-osteoclast co-culture.
    Hayden RS; Quinn KP; Alonzo CA; Georgakoudi I; Kaplan DL
    Biomaterials; 2014 Apr; 35(12):3794-802. PubMed ID: 24484674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw.
    Manzano-Moreno FJ; Ramos-Torrecillas J; Melguizo-Rodríguez L; Illescas-Montes R; Ruiz C; García-Martínez O
    Int J Med Sci; 2018; 15(4):359-367. PubMed ID: 29511371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
    Frith JC; Rogers MJ
    J Bone Miner Res; 2003 Feb; 18(2):204-12. PubMed ID: 12568397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of alendronate doped calcium phosphates on bone cells activity.
    Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A
    Bone; 2012 Nov; 51(5):944-52. PubMed ID: 22878156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro.
    Boanini E; Torricelli P; Gazzano M; Fini M; Bigi A
    Biomaterials; 2012 Jan; 33(2):722-30. PubMed ID: 22014461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.
    Kellinsalmi M; Mönkkönen H; Mönkkönen J; Leskelä HV; Parikka V; Hämäläinen M; Lehenkari P
    Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):382-91. PubMed ID: 16364054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures.
    Wang Y; Panasiuk A; Grainger DW
    Mol Pharm; 2011 Aug; 8(4):1016-24. PubMed ID: 21186792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoblast: osteoclast co-cultures on silk fibroin, chitosan and PLLA films.
    Jones GL; Motta A; Marshall MJ; El Haj AJ; Cartmell SH
    Biomaterials; 2009 Oct; 30(29):5376-84. PubMed ID: 19647869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
    Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
    Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antioxidant and bone repair properties of quercetin-functionalized hydroxyapatite: An in vitro osteoblast-osteoclast-endothelial cell co-culture study.
    Forte L; Torricelli P; Boanini E; Gazzano M; Rubini K; Fini M; Bigi A
    Acta Biomater; 2016 Mar; 32():298-308. PubMed ID: 26689470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Alendronate release from a calcium phosphate bone cement: An in vitro osteoblast-osteoclast co-culture study.
    Dolci LS; Panzavolta S; Torricelli P; Albertini B; Sicuro L; Fini M; Bigi A; Passerini N
    Int J Pharm; 2019 Jan; 554():245-255. PubMed ID: 30423416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect osteoblast differentiation by liposomal clodronate.
    Okada E; Nakata H; Yamamoto M; Kasugai S; Kuroda S
    J Cell Mol Med; 2018 Feb; 22(2):1127-1137. PubMed ID: 29063674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
    Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
    Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin and alendronate multi-functionalized materials as tools to hinder oxidative stress damage.
    Forte L; Torricelli P; Boanini E; Rubini K; Fini M; Bigi A
    J Biomed Mater Res A; 2017 Dec; 105(12):3293-3303. PubMed ID: 28865182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of alendronate eluting chitosan scaffold can effectively increase osteoblast functions and inhibit osteoclast differentiation.
    Kim SE; Suh DH; Yun YP; Lee JY; Park K; Chung JY; Lee DW
    J Mater Sci Mater Med; 2012 Nov; 23(11):2739-49. PubMed ID: 22850978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells.
    Boanini E; Torricelli P; Gazzano M; Giardino R; Bigi A
    Biomaterials; 2008 Mar; 29(7):790-6. PubMed ID: 18022226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-dependent effects of alendronate and pamidronate functionalized gold nanoparticles on osteoclast and osteoblast viability.
    Conners CM; Bhethanabotla VR; Gupta VK
    J Biomed Mater Res B Appl Biomater; 2017 Jan; 105(1):21-29. PubMed ID: 26372402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates inhibit IL-6 production by human osteoblast-like cells.
    Giuliani N; Pedrazzoni M; Passeri G; Girasole G
    Scand J Rheumatol; 1998; 27(1):38-41. PubMed ID: 9506876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.